TREM2 and Alzheimer disease: Notably, genetic studies have implicated microglial dysfunction in AD risk: rare variants in microglial genes such as TREM2, which encodes an innate immune receptor on microglia, substantially increase AD risk, presumably by impairing microglial ability to respond to and clear amyloid.